As part of a report on incentivizing use of accountable care organizations (ACOs), Congress’ primary research arm recently recommended excluding [...] …
Category: Federal
The 340B drug discount program—and congressional activity associated with it—remained a hot topic for lobbyists in the first three months [...] …
Following the recent death of former Arkansas governor and U.S. Sen. David Pryor, he is being remembered for his important [...] …
After missing its self-imposed deadline of the end of 2023, the White House this week completed its review to implement [...] …
While the Biden administration’s proposal to address drug shortages does not exempt certain drug products from 340B pricing like the [...] …
Stakeholders disagreed on whether Congress should codify a new 340B patient definition or restrict how providers use 340B savings, in [...] …
Less than four days remain for stakeholders to comment on the highly anticipated bipartisan senate draft 340B program overhaul, and [...] …
An influential conservative congressional caucus is urging Congress to significantly cut Medicaid spending and “ to ensure that drug discounts [...] …
Long-awaited federal legislation to bar drugmaker restrictions on 340B contract pharmacy arrangements was introduced today. The Mar 12 bill sponsored [...] …
Despite the looming finalization of a major policy change, this week’s fiscal year 2025 budget request would freeze the budget [...] …